Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2013-11, Vol.122 (22), p.3694-3696
Hauptverfasser:	Grisouard, Jean, Ojeda-Uribe, Mario, Looser, Renate, Hao-Shen, Hui, Lundberg, Pontus, Duek, Adrian, Jeandidier, Eric, Karow, Axel, Skoda, Radek C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Clone Cells - pathology Dasatinib Female Genes, abl Humans Hydroxyurea - therapeutic use Janus Kinase 2 - genetics Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Middle Aged Point Mutation Pyrimidines - therapeutic use Thiazoles - therapeutic use Thrombocythemia, Essential - complications Thrombocythemia, Essential - drug therapy Thrombocythemia, Essential - genetics Translocation, Genetic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!